Abstract:Background Bipolar affective disorder (BPAD) and major depressive disorder (MDD) are two mood disorders whose pathophysiology may involve the purinergic system. Elevated uric acid levels, associated with this system, can impact various behaviors in individuals affected by these conditions. In addition to genetic predisposition, blood uric acid levels can be impacted by various factors, including metabolic syndrome, the consumption of psychoactive medications, and other underlying kidney conditions such as gout. Objective The study aims to investigate the relationship between blood uric acid levels and mental health conditions, specifically BPAD subtypes (manic and depressive) and MDD. The study also examines changes in blood uric acid levels following treatment and evaluates the effectiveness of different treatment approaches in reducing uric acid levels. Methodology To be eligible to participate, individuals must have a confirmed diagnosis of BPAD (manic or depressive type) or MDD, according to the International Classification of Diseases (ICD-10). Blood uric acid levels were measured at both baseline and follow-up assessments. Symptoms were assessed weekly using standardized rating scales (Young Mania Rating Scale (YMRS) and Hamilton Rating Scale for Depression (HAM-D)) until treatment response was achieved, which was defined as a 50% reduction in initial scores on both scales. We used ANOVA to examine the differences among the three patient groups and paired sample t-tests to examine the changes in means before and after treatment conditions. Results A significant positive correlation was found between the severity of illness and serum uric acid levels across all three patient groups: those with BPAD-mania, BPAD-depression, and MDD. Notably, patients with BPAD-mania patients had significantly higher serum uric acid levels (5.2±0.9 mg/dL) compared to those with BPAD-depression (4.8±1.0 mg/dL) and MDD (4.0±1.1 mg/dL). After treatment, all patient groups exhibited a decrease in serum uric acid levels. The reduction in serum uric acid levels was pronounced in all patient groups, with decreases of 3.1±0.8 mg/dL in patients with BPAD-mania, 3.1±0.9 mg/dL in those with BPAD-depression, and 3.5±1.1 mg/dL in those with MDD. The study showed that the reduction in serum uric acid levels was significantly correlated with the severity of illness in patients with BPAD-mania, but not in those with BPAD-depression or MDD. Furthermore, the study found that treatment with lithium carbonate, sodium valproate, or carbamazepine was equally effective in reducing serum uric acid levels, regardless of the mood stabilizer used. Conclusion The study supports that dysfunction in the purine system might play a significant role in the development and progression of BPAD, suggesting that this phenomenon is not solely due to chronicity or medication exposure. This study also introduces a fresh perspective on the underlying biological processes that contribute to the development of BPAD and also sheds light on new treatment regimens targeting uric acid reduction in treating patients with bipolar disorder.

Study on the level of serum uric acid in first-episode and unmedicated patients with manic episode

The study on the levels of serum uric acid in patients with bipolar disorder

Study on the Prevalence and relative factors of hyPeruricemia in the Patients with manic ePisodes of bi-Polar I disorder

Study on the level and relative factors of serum uric acid in the patients with depressive episodes of bipolar I disorder

Serum uric acid a depression biomarker.

Patients with Drug-Naive Bipolar Disorder in Remission after 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Study on Serum Concentrations of Homocysteine and Relation Factors in the Patients with Manic Episodes of Bipolar Ⅰ Disorder

Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Serum uric acid level in drug-naive depressed patients

Changes and its significance of serum thyroid hormone levels in mood disorder patients with the first manic episode

Serum Uric Acid Levels and the Clinical Characteristics of Depression.

Clinical study on the correlation between serum uric acid and other metabolic indexes

Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study

Relationship Between Serum Uric Acid and Selected Cardiovascular Risk Factors in Hangzhou Populations

A large-scale study on uric acid-related biomarkers in patients with bipolar disorder

Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response

High Serum Uric Acid Level in Adolescent Depressive Patients

Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study

Serum uric acid as an independent predictor for hospital mortality and cardiac shock in patients with acute myocardial infarction

Correlation between male serum uric acid and serum lipids and its associated ratios

Clinical Significance of Serum Uric Acid Level in Hyperthyroidism Patients with Different Sex